Showing results (11-20 of 210) with videos related to
Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|May 11, 2002
In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureusJana M Swenson, Fred C TenoverAntibiotics (Basel, Switzerland)|February 25, 2022
Detection of Methicillin-Resistant Staphylococcus aureus Infections Using Molecular MethodsFred C Tenover, Isabella A TicklerExpert Opinion on Medical Diagnostics|March 14, 2013
Methicillin-resistant Staphylococcus aureus diagnostics: state of the artEllen Jo Baron, Fred C TenoverClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2007
The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureusFred C Tenover, Robert C MoelleringCurrent Opinion in Infectious Diseases|June 30, 2005
Vancomycin-resistant staphylococci and enterococci: epidemiology and controlFred C Tenover, L Clifford McDonaldAntibiotics (Basel, Switzerland)|September 28, 2024
Genomic Analysis of Enterobacter Species Isolated from Patients in United States HospitalsFred C Tenover, Isabella A TicklerThe Journal of Antimicrobial Chemotherapy|July 18, 2009
Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiologyFred C Tenover, Richard V GoeringJournal of Clinical Microbiology|August 6, 2005
Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus sppJana M Swenson, Fred C Tenover, Pharmacotherapy|May 19, 2012
iPhones, iPads, and medical applications for antimicrobial stewardshipDebra A GoffCurrent Opinion in Infectious Diseases|June 25, 2003
Cost effective approaches to antimicrobial use in oncology patientsDebra A GoffPageof 21